APA (7th ed.) Citation

AM, R., C, J., S, P., L, D., CL, S., & S, G. (2023). Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis. Cancers, 15(17), . https://doi.org/10.3390/cancers15174264

Chicago Style (17th ed.) Citation

AM, Roy, Jiang C, Perimbeti S, Deng L, Shapiro CL, and Gandhi S. "Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis." Cancers 15, no. 17 (2023). https://doi.org/10.3390/cancers15174264.

MLA (9th ed.) Citation

AM, Roy, et al. "Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis." Cancers, vol. 15, no. 17, 2023, https://doi.org/10.3390/cancers15174264.